参考文献:1. Dufau, M. L. (1998). / Annu. Rev. Physiol. 60, 461-96. CrossRef 2. Hai, M. V., De Roux, N., Ghinea, N., et al. (1999). / Ann. Endocrinol. 60, 89-2. 3. Gilman, A. G. (1987). / Annu. Rev. Biochem. 56, 615-49. CrossRef 4. Ulloa-Aguirre, A. and Conn, P. M. (1998). In: / Handbook of physiology. Conn, P. M. (ed.). Oxford University Press: New York. 5. Druey, K. M., Blumer, K. J., Kang, V. H., and Kehrl, J. H. (1996). / Nature 379, 742-46. CrossRef 6. Dohlman, H. G. and Thorner, J. (1997). / J. Biol. Chem. 272, 3871-874. CrossRef 7. De Vries, L., Zheng, B., Fischer, T., Elenko, E., and Farquhar, M. (2000). / Annu. Rev. Pharmacol. Toxicol. 40, 235-71. CrossRef 8. Chasse, S. A. and Dohlman, H. G. (2003). / Assay Drug Dev. Technol. 1, 357-64. CrossRef 9. Kehrl, J. H. (1998). / Immunity 8, 1-0. CrossRef 10. Burchett, S. A. (2000). / J. Neurochem. 75, 1335-351. CrossRef 11. Kozasa, T. (2001). / Life Sci. 68, 2309-317. CrossRef 12. Castro-Fernández, C. and Conn P. M. (2002). / Mol. Cell. Endocrinol. 191, 149-56. CrossRef 13. Xu, X., Zeng, W., Popov, S., et al. (1999). / J. Biol. Chem. 274, 3549-556. CrossRef 14. Scheschonka, A., Dessauer, C. W., Sinnarajah, S., Chidiac, P., Shi, C. S., and Kehrl, J. H. (2000). / Mol. Pharmacol. 58, 719-28. 15. Tseng, C.-C. and Zhang, X.-Y. (1998). / Endocrinology 139, 4470-475. CrossRef 16. Versele, M., De Winde, J. H., and Thevelein, J. M. (1999). / EMBO J. 18, 5577-591. CrossRef 17. Sinnarajah, S., Dessauer, C. W., Srikumar, D., et al. (2001). / Nature 409, 1051-055. CrossRef 18. Chatterjee, T. K., Eapen, A. K., and Fisher, R. A. (1997). / J. Biol. Chem. 272, 15481-5487. CrossRef 19. Shi, C.-S., Lee, S. B., Sinnarajah, S., Dessauer, C. W., Rhee, S. G., and Kehrl, J. H. (2001). / J. Biol. Chem. 276, 24293-4300. CrossRef 20. Castro-Fernández, C., Janovick, J. A., Brothers, S. P., Fisher, R. A., Ji, T. H., and Conn, P. M. (2002). / Endocrinology 143, 1310-317. CrossRef 21. Chatterjee, T. K. and Fisher, R. A. (2000). / J. Biol. Chem. 275, 24013-4021. CrossRef 22. Burchett, S. A. (2003). / J. Neurochem. 87, 551-59. CrossRef 23. De Vries, L. and Farquhar, M. G. (1999). / Trends Cell. Biol. 9, 138-44. CrossRef 24. Anger, T., Zhang, W., and Mende, U. (2004). / J. Biol. Chem. 279, 3906-915. CrossRef 25. Ghavami, A., Hunt, R. A., Olsen, M. A., et al. (2004). / Cell. Signal. 16, 711-21. CrossRef 26. Lin, X., Janovick, J. A., Brothers, S., Bl?menrohr, M., Bogerd, J., and Conn, P. M. (1998). / Mol. Endocrinol. 12, 161-71. CrossRef 27. Brothers, S. P., Janovick, J. A., and Conn, P. M. (2003). / J. Clin. Endocrinol. Metab. 88, 6107-2. CrossRef 28. Huckle, W. R. and Conn, P. M. (1987). / Meth. Enzymol. 141, 149-55. CrossRef
作者单位:C. Castro-Fernández (1) G. Maya-Nú?ez (1) J. P. Méndez (1)
1. Research Unit in Developmental Biology, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, 06703, México, D.F., México
文摘
Follicle-stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) belong to the super-family of G protein-coupled receptors (GPCR); GPCRs are negatively regulated by RGS ("regulators of G protein signaling") proteins. In this study we evaluated the effects of RGS3 and RGS10 on FSHR and LHR ligand binding and effector coupling. FSHR and LHR ligand binding were unchanged in the presence of RGS3 or RGS10. However, signaling by FSHR and LHR was diminished by RGS3 but not by RGS10. This constitutes the first demonstration of an interaction between RGS proteins and LH and FSH signaling pathways and identifies a mechanism for negative regulation of RGS3 on FSHR and LHR signaling.